OrganiGram Holdings Inc. (OGI.TO)
CAD 1.59
(0.63%)
CAD 1.59
(0.63%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 155 Thousand CAD | 40.57% |
| 2022 | 3.35 Million CAD | -32.33% |
| 2021 | 4.96 Million CAD | -95.21% |
| 2020 | 103.67 Million CAD | 109.12% |
| 2019 | 49.57 Million CAD | -50.01% |
| 2018 | 99.16 Million CAD | 2718.52% |
| 2017 | 3.51 Million CAD | -53.04% |
| 2016 | 7.49 Million CAD | 54.18% |
| 2015 | 4.85 Million CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 100 Thousand CAD | -15.25% |
| 2024 Q1 | 136 Thousand CAD | -97.12% |
| 2024 Q2 | 118 Thousand CAD | -13.24% |
| 2023 Q4 | 4.71 Million CAD | 2521.67% |
| 2023 Q1 | 217 Thousand CAD | -93.54% |
| 2023 Q2 | 198 Thousand CAD | -8.76% |
| 2023 Q3 | 180 Thousand CAD | -9.09% |
| 2023 FY | 4.71 Million CAD | 40.57% |
| 2022 Q2 | 7.84 Million CAD | 148.73% |
| 2022 Q4 | 3.35 Million CAD | -55.74% |
| 2022 FY | 3.35 Million CAD | -32.33% |
| 2022 Q1 | 3.15 Million CAD | -36.42% |
| 2022 Q3 | 7.58 Million CAD | -3.31% |
| 2021 Q2 | 3.51 Million CAD | -97.05% |
| 2021 Q3 | 5.22 Million CAD | 48.69% |
| 2021 FY | 4.96 Million CAD | -95.21% |
| 2021 Q4 | 4.96 Million CAD | -5.11% |
| 2021 Q1 | 119.04 Million CAD | 14.83% |
| 2020 FY | 103.67 Million CAD | 109.12% |
| 2020 Q3 | 88.19 Million CAD | 1.4% |
| 2020 Q2 | 86.98 Million CAD | 0.72% |
| 2020 Q1 | 86.36 Million CAD | 74.2% |
| 2020 Q4 | 103.67 Million CAD | 17.55% |
| 2019 Q4 | 49.57 Million CAD | 0.22% |
| 2019 FY | 49.57 Million CAD | -50.01% |
| 2019 Q3 | 49.46 Million CAD | -20.57% |
| 2019 Q2 | 62.27 Million CAD | -36.91% |
| 2019 Q1 | 98.72 Million CAD | -0.45% |
| 2018 Q4 | 99.16 Million CAD | 0.48% |
| 2018 FY | 99.16 Million CAD | 2718.52% |
| 2018 Q1 | 3.4 Million CAD | -3.17% |
| 2018 Q2 | 96.28 Million CAD | 2726.47% |
| 2018 Q3 | 98.68 Million CAD | 2.49% |
| 2017 Q2 | 3.64 Million CAD | -2.63% |
| 2017 Q1 | 3.74 Million CAD | -50.05% |
| 2017 FY | 3.51 Million CAD | -53.04% |
| 2017 Q4 | 3.51 Million CAD | -1.47% |
| 2017 Q3 | 3.57 Million CAD | -2.0% |
| 2016 Q4 | 7.49 Million CAD | -1.04% |
| 2016 Q3 | 7.57 Million CAD | -1.02% |
| 2016 Q2 | 7.64 Million CAD | 3.14% |
| 2016 Q1 | 7.41 Million CAD | 52.62% |
| 2016 FY | 7.49 Million CAD | 54.18% |
| 2015 FY | 4.85 Million CAD | 0.0% |
| 2015 Q4 | 4.85 Million CAD | 102.05% |
| 2015 Q3 | 2.4 Million CAD | -1.75% |
| 2015 Q2 | 2.44 Million CAD | -1.21% |
| 2015 Q1 | 2.47 Million CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 104.79 Million CAD | 99.852% |
| Avicanna Inc. | 1.8 Million CAD | 91.405% |
| Avant Brands Inc. | 18.7 Million CAD | 99.171% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | 2.228% |
| Crescita Therapeutics Inc. | 1.25 Million CAD | 87.64% |
| Knight Therapeutics Inc. | 69.09 Million CAD | 99.776% |
| MediPharm Labs Corp. | 2.29 Million CAD | 93.246% |
| Canopy Growth Corporation | 683.17 Million CAD | 99.977% |
| Willow Biosciences Inc. | 2.15 Million CAD | 92.811% |
| Auxly Cannabis Group Inc. | 159.04 Million CAD | 99.903% |